Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Goodwill & Intangibles: 2019-2025

Historic Goodwill & Intangibles for CorMedix (CRMD) over the last 1 years, with Sep 2025 value amounting to $411.4 million.

  • CorMedix's Goodwill & Intangibles rose 21597.93% to $411.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $411.4 million, marking a year-over-year increase of 21597.93%. This contributed to the annual value of $2.0 million for FY2024, which is N/A change from last year.
  • Per CorMedix's latest filing, its Goodwill & Intangibles stood at $411.4 million for Q3 2025, which was up 23,541.02% from $1.7 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Goodwill & Intangibles peaked at $411.4 million during Q3 2025, and registered a low of $1.7 million during Q2 2025.
  • Moreover, its 2-year median value for Goodwill & Intangibles was $1.9 million (2024), whereas its average is $83.8 million.
  • Data for CorMedix's Goodwill & Intangibles shows a peak YoY soared of 21,597.93% (in 2025) over the last 5 years.
  • CorMedix's Goodwill & Intangibles (Quarterly) stood at $2.0 million in 2024, then spiked by 21,597.93% to $411.4 million in 2025.
  • Its Goodwill & Intangibles was $411.4 million in Q3 2025, compared to $1.7 million in Q2 2025 and $1.8 million in Q1 2025.